Flavonoids from Enicostema littorale blume enhances glucose uptake of cells in insulin resistant human liver cancer (HepG2) cell line via IRS-1/PI3K/Akt pathway

Biomed Pharmacother. 2017 Jun:90:268-277. doi: 10.1016/j.biopha.2017.03.047. Epub 2017 Mar 30.

Abstract

Diabetes mellitus has spread over the world with 347 million people affected. Insulin resistance is a main pathogenic event in Type 2 Diabetes Mellitus (T2DM) leading to a reduction in glucose uptake by peripheral tissue and increased hepatic glucose output. In this study, we have isolated four flavonoid rich fractions fraction A (FA), fraction B (FB), fraction C (FC) and fraction D (FD) from Enicostema littorale. All the fractions were preliminary screened for TLC fingerprinting, total flavonoid content. Total eight flavonoids were identified by LC/MS. Insulin resistant HepG2 (IR/HepG2) model was established by inducing insulin resistance in HepG2 cells to investigate the effect of these fractions on IR/HepG2 cell line for their glucose uptake. The results showed the significant dose dependant increase in glucose uptake of cells treated with FD. It showed significant activity at a concentration of 10μg/ml. The LC/MS results of FD demonstrated the presence of C-glycoside Swertisin which could be responsible for the effect. Further, to investigate the mechanism of action, gene expression for insulin receptor substrate 1 (IRS-1), protein kinase B (Akt-2) and glucose transporter 4 (GLUT-4) genes were evaluated by real time PCR. A significant upregulation of these genes was observed in FD treated samples, thereby indicating the enhancement of glucose uptake rate of cells via IRS-1/PI3K/Akt pathway.

Keywords: E. littorale; Flavonoids; Glucose transporters; Glucose uptake assay; HepG2 cell line; Insulin receptors; LC/MS.

MeSH terms

  • Cell Line, Tumor
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / metabolism
  • Flavonoids / pharmacology*
  • Gentianaceae / chemistry*
  • Glucose / metabolism*
  • Glucose Transporter Type 4 / metabolism
  • Glycosides
  • Hep G2 Cells
  • Humans
  • Insulin / metabolism
  • Insulin Receptor Substrate Proteins / metabolism*
  • Insulin Resistance / physiology*
  • Liver Neoplasms
  • Monosaccharides / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphorylation / drug effects
  • Plant Extracts / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Receptor, Insulin / metabolism
  • Signal Transduction / drug effects
  • Up-Regulation / drug effects

Substances

  • C-glycoside
  • Flavonoids
  • Glucose Transporter Type 4
  • Glycosides
  • IRS1 protein, human
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Monosaccharides
  • Plant Extracts
  • Receptor, Insulin
  • Proto-Oncogene Proteins c-akt
  • Glucose